Structure-function investigation of Vsp serotypes of the spirochete Borrelia hermsii

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Mehra, Rohit ^a   Londoño, Diana ^a,b   Sondey, Marie ^a   Lawson, Catherine ^c   Cadavid, Diego ^a,b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PROTEIN VSP 1; PROTEIN VSP 2; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; OUTER MEMBRANE PROTEIN; PRIMER DNA; VSP PROTEIN, BACTERIAL;

ANIMAL EXPERIMENT; ARTICLE; BORRELIA; BORRELIA HERMSII; BORRELIA INFECTION; BORRELIA TURICATAE; CLUSTER ANALYSIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISEASE SEVERITY; DNA SEQUENCE; FEMALE; MOUSE; NONHUMAN; PHYLOGENETIC TREE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SEROTYPE; SPIROCHETE; TISSUE DISTRIBUTION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; CONFORMATION; GENETICS; METABOLISM; MOUSE MUTANT; PHYLOGENY; POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION;

BORRELIA HERMSII; BORRELIA TURICATAE; MUS; SPIROCHAETALES;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BORRELIA; CLUSTER ANALYSIS; DNA PRIMERS; FEMALE; MICE; MICE, INBRED BALB C; MICE, SCID; MOLECULAR CONFORMATION; PHYLOGENY; POLYMERASE CHAIN REACTION; SPIROCHAETALES; STRUCTURE-ACTIVITY RELATIONSHIP; TISSUE DISTRIBUTION;

EID: 70449570564     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007597     Document Type: Article

References (46)

1. Barbour AG, Hayes SF (1986) Biology of Borrelia species. Microbiol Rev 50: 381-400.
2. Barbour AG, Dai Q, Restrepo BI, Stoenner HG, Frank SA (2006) Pathogen escape from host immunity by a genome program for antigenic variation. Proc Natl Acad Sci U S A 103: 18290-18295.
3. Barbour AG, Bundoc V (2001) In vitro and in vivo neutralization of the relapsing fever agent Borrelia hermsii with serotype-specific immunoglobulin M antibodies. Infect Immun 69: 1009-1015.
4. Connolly SE, Benach JL (2001) Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies. J Immunol 167: 3029-3032.
5. Hinnebusch BJ, Barbour AG, Restrepo BI, Schwan TG (1998) Population structure of the relapsing fever spirochete Borrelia hermsii as indicated by polymorphism of two multigene families that encode immunogenic outer surface lipoproteins. Infect Immun 66: 432-440.
6. Dai Q, Restrepo BI, Porcella SF, Raffel SJ, Schwan TG, et al. (2006) Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids. Mol Microbiol 60: 1329-1343.
7. Cadavid D, Pachner AR, Estanislao L, Patalapati R, Barbour AG (2001) Isogenic serotypes of Borrelia turicatae show different localization in the brain and skin of mice. Infect Immun 69: 3389-3397.
8. Cadavid D, Thomas DD, Crawley R, Barbour AG (1994) Variability of a bacterial surface protein and disease expression in a possible mouse model of systemic Lyme borreliosis. J Exp Med 179: 631-642.
9. Gelderblom H, Schmidt J, Londono D, Bai Y, Quandt J, et al. (2007) Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae. Am J Pathol 170: 251-262.
10. Sethi N, Sondey M, Bai Y, Kim KS, Cadavid D (2006) Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infect Immun 74: 6408-6418.
11. Pennington PM, Allred CD, West CS, Alvarez R, Barbour AG (1997) Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease. Infect Immun 65: 285-292.
12. Londoño D, Bai Y, Zuckert WR, Gelderblom H, Cadavid D (2005) Cardiac apoptosis in severe relapsing fever borreliosis. Infect Immun 73: 7669-7676.
13. Cadavid D, Garcia E, Gelderblom H (2007) Coinfection with Borrelia turicatae serotype 2 prevents the severe vestibular dysfunction and earlier mortality caused by serotype 1. J Infect Dis 195: 1686-1693.
14. Gelderblom H, Londono D, Bai Y, Cabral ES, Quandt J, et al. (2007) High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae. J Neuropathol Exp Neurol 66: 208-217.
15. Londono D, Carvajal J, Arguelles-Grande C, Marques A, Cadavid D (2008) Interleukin 10 protects the brain microcirculation from Spirochetal injury. J Neuropathol Exp Neurol 67.
16. Londono D, Marques A, Hornung RL, Cadavid D (2008) IL-10 helps control pathogen load during high-level bacteremia. J Immunol 181: 2076-2083.
17. Londoño Diana MA, Hornung Ronald L, Cadavid Diego (2008) Relapsing Fever Borreliosis in IL-10 Deficient Mice. Infection and immunity 77: 5508-5513.
18. Barbour AG, Carter CJ, Sohaskey CD (2000) Surface protein variation by expression site switching in the relapsing fever agent Borrelia hermsii. Infect Immun 68: 7114-7121.
19. Zuckert WR, Kerentseva TA, Lawson CL, Barbour AG (2001) Structural conservation of neurotropism-associated VspA within the variable Borrelia Vsp-OspC lipoprotein family. J Biol Chem 276: 457-463.
20. Lawson CL, Yung BH, Barbour AG, Zuckert WR (2006) Crystal structure of neurotropism-associated variable surface protein 1 (Vsp1) of Borrelia turicatae. J Bacteriol 188: 4522-4530.
21. Kumaran D, Eswaramoorthy S, Luft BJ, Koide S, Dunn JJ, et al. (2001) Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi. Embo J 20: 971-978.
22. Cadavid D, Bundoc V, Barbour AG (1993) Experimental infection of the mouse brain by a relapsing fever Borrelia species: a molecular analysis. J Infect Dis 168: 143-151.
23. Cadavid D, Pennington PM, Kerentseva TA, Bergstrom S, Barbour AG (1997) Immunologic and genetic analyses of VmpA of a neurotropic strain of Borrelia turicatae. Infect Immun 65: 3352-3360.
24. Pennington PM, Cadavid D, Barbour AG (1999) Characterization of VspB of Borrelia turicatae, a major outer membrane protein expressed in blood and tissues of mice. Infect Immun 67: 4637-4645.
25. Stoenner HG, Dodd T, Larsen C (1982) Antigenic variation of Borrelia hermsii. J Exp Med 156: 1297-1311.
26. Zuckert WR, Lloyd JE, Stewart PE, Rosa PA, Barbour AG (2004) Cross-species surface display of functional spirochetal lipoproteins by recombinant Borrelia burgdorferi. Infect Immun 72: 1463-1469.
27. Eicken C, Sharma V, Klabunde T, Owens RT, Pikas DS, et al. (2001) Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi. J Biol Chem 276: 10010-10015.
28. Fiser A, Sali A (2003) Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 374: 461-491.
29. Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 31: 3381-3385.
30. Engh RA, Huber R (1991) Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallogr A 47: 392-400.
31. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 53: 240-255.
32. Carter CJ, Bergstrom S, Norris SJ, Barbour AG (1994) A family of surface-exposed proteins of 20 kilodaltons in the genus Borrelia. Infect Immun 62: 2792-2799.
33. Li H, Dunn JJ, Luft BJ, Lawson CL (1997) Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab. Proc Natl Acad Sci U S A 94: 3584-3589.
34. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, et al. (2003) The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol 170: 3819-3827.
35. Barbour AG, Burman N, Carter CJ, Kitten T, Bergstrom S (1991) Variable antigen genes of the relapsing fever agent Borrelia hermsii are activated by promoter addition. Mol Microbiol 5: 489-493.
36. Lin T, Oliver JH, Jr., Gao L (2003) Comparative analysis of Borrelia isolates from southeastern USA based on randomly amplified polymorphic DNA fingerprint and 16S ribosomal gene sequence analyses. FEMS Microbiol Lett 228: 249-257.
37. Cadavid D, Barbour AG (1998) Neuroborreliosis during relapsing fever: review of the clinical manifestations, pathology, and treatment of infections in humans and experimental animals. Clin Infect Dis 26: 151-164.
38. French CJ, Gosline JM (1978) Pressure effects on water-swollen elastin. A model for hydrophobic interactions in proteins. Biochim Biophys Acta 537: 386-395.
39. Magoun L, Zuckert WR, Robbins D, Parveen N, Alugupalli KR, et al. (2000) Variable small protein (Vsp)-dependent and Vsp-independent pathways for glycosaminoglycan recognition by relapsing fever spirochaetes. Mol Microbiol 36: 886-897.
40. Porcella SF, Raffel SJ, Anderson DE, Jr., Gilk SD, Bono JL, et al. (2005) Variable tick protein in two genomic groups of the relapsing fever spirochete Borrelia hermsii in western North America. Infect Immun 73: 6647-6658.
41. Deitsch KW, Moxon ER, Wellems TE (1997) Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol Mol Biol Rev 61: 281-293.
42. Tilly K, Krum JG, Bestor A, Jewett MW, Grimm D, et al. (2006) Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect Immun 74: 3554-3564.
43. Grimm D, Tilly K, Byram R, Stewart PE, Krum JG, et al. (2004) Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci U S A 101: 3142-3147.
44. Tilly K, Bestor A, Jewett MW, Rosa P (2007) Rapid clearance of Lyme disease spirochetes lacking OspC from skin. Infect Immun 75: 1517-1519.
45. Byram R, Stewart PE, Rosa P (2004) The essential nature of the ubiquitous 26-kilobase circular replicon of Borrelia burgdorferi. J Bacteriol 186: 3561-3569.
46. Bunikis J, Tsao J, Garpmo U, Berglund J, Fish D, et al. (2004) Typing of Borrelia relapsing fever group strains. Emerg Infect Dis 10: 1661-1664.